Case | 19 May 2017

Setterwalls has advised Diamyd Medical in rights issue

Responsive image

Setterwalls has acted as legal adviser to Diamyd Medical AB (publ) in connection with rights issue.

Diamyd Medical develops vaccine to considerably improve the life quality for persons with different types of diabetes and inflammatory diseases.

Contact:

Marcus Nivinger, Linnea Gävbo

Practice areas:

Equity Capital Markets

  • This field is for validation purposes and should be left unchanged.

Vill du komma i kontakt med oss?

Fyll i formuläret samt vilket kontor du vill bli kontaktad av, så hör vi av oss inom kort.

Related news

Setterwalls has advised Sleep Cycle in connection with the proposed acquisition of Audiowell for approximately SEK 2.3 billion

Case | 12 October 2026

Setterwalls has advised Sleep Cycle in connection with the proposed acquisition of Audiowell for approximately...

Read more
Setterwalls has advised Integrum AB in connection with a private placement of approximately SEK 22.9 million

Case | 30 September 2026

Setterwalls has advised Integrum AB in connection with a private placement of approximately SEK 22.9 million

Read more
Setterwalls has advised Hexicon in connection with the extension of a cross-border loan facility with Nuveen

Case | 14 September 2026

Setterwalls has advised Hexicon in connection with the extension of a cross-border loan facility with Nuveen

Read more
Load more